Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and dalcetrapib

fluorodeoxyglucose f18 has been researched along with dalcetrapib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bansilal, S; Burgess, T; Farkouh, ME; Fayad, ZA; Fuster, V; Kallend, D; Mani, V; Pozza, J; Rudd, JH; Tawakol, A; Woodward, M1
Duivenvoorden, R; Farkouh, ME; Fayad, ZA; Fuster, V; Kallend, D; Mani, V; Rudd, JHF; Suchankova, G; Tawakol, A; Woodward, M1
Abt, M; Bucerius, J; Fayad, ZA; Kallend, D; Mani, V; Rudd, JH; Samber, D; Tawakol, A; Woodward, M1

Trials

2 trial(s) available for fluorodeoxyglucose f18 and dalcetrapib

ArticleYear
Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    American heart journal, 2011, Volume: 162, Issue:2

    Topics: Adolescent; Adult; Aged; Amides; Anticholesteremic Agents; Coronary Disease; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Esters; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sulfhydryl Compounds; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2011
Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
    JACC. Cardiovascular imaging, 2013, Volume: 6, Issue:10

    Topics: Amides; Aorta; Aortic Diseases; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Double-Blind Method; Esters; Fluorodeoxyglucose F18; Humans; Hypolipidemic Agents; Inflammation Mediators; Longitudinal Studies; Multimodal Imaging; Peroxidase; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sulfhydryl Compounds; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2013

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and dalcetrapib

ArticleYear
Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study.
    The international journal of cardiovascular imaging, 2014, Volume: 30, Issue:3

    Topics: Amides; Anticholesteremic Agents; Coronary Artery Disease; Esters; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sulfhydryl Compounds; Tomography, X-Ray Computed; Treatment Outcome

2014